The risk of severe adverse reactions to neffy intranasal epinephrine spray

Brian Lee¹, Ryan Gauld², Harold Kim³

Affiliations

¹ Department of Medicine, Western University, London, Ontario, Canada; Division of Clinical Immunology and Allergy, Western University, London, Ontario, Canada. Electronic address: brianlwj@gmail.com.
² Department of Medicine, Western University, London, Ontario, Canada; Division of Clinical Immunology and Allergy, Western University, London, Ontario, Canada.
³ Department of Medicine, Western University, London, Ontario, Canada; Division of Clinical Immunology and Allergy, Western University, London, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

PMID: 38069977
DOI: 10.1016/j.jaci.2023.11.015

Comment

The risk of severe adverse reactions to neffy intranasal epinephrine spray

Brian Lee et al. J Allergy Clin Immunol. 2024 Feb.

. 2024 Feb;153(2):535-536.

doi: 10.1016/j.jaci.2023.11.015. Epub 2023 Dec 6.

Authors

Brian Lee¹, Ryan Gauld², Harold Kim³

Affiliations

¹ Department of Medicine, Western University, London, Ontario, Canada; Division of Clinical Immunology and Allergy, Western University, London, Ontario, Canada. Electronic address: brianlwj@gmail.com.
² Department of Medicine, Western University, London, Ontario, Canada; Division of Clinical Immunology and Allergy, Western University, London, Ontario, Canada.
³ Department of Medicine, Western University, London, Ontario, Canada; Division of Clinical Immunology and Allergy, Western University, London, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

PMID: 38069977
DOI: 10.1016/j.jaci.2023.11.015

No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure statement Disclosure of potential conflict of interest: H. Kim reports serving as a medical lecturer and/or advisory board member for ALK, AstraZeneca, Bausch Health, CSL Behring, GSK, Miravo, Novartis, Medexus, Pfizer, Sanofi, Takeda, and Valeopharma. The rest of the authors declare that they have no relevant conflicts of interest.

Comment in

Reply.
Casale TB, Ellis AK, Nowak-Wegrzyn A, Kaliner M, Lowenthal R, Tanimoto S. Casale TB, et al. J Allergy Clin Immunol. 2024 Feb;153(2):536-537. doi: 10.1016/j.jaci.2023.10.030. Epub 2023 Dec 6. J Allergy Clin Immunol. 2024. PMID: 38069978 No abstract available.

Comment on

Pharmacokinetics/pharmacodynamics of epinephrine after single and repeat administration of neffy, EpiPen, and manual intramuscular injection.
Casale TB, Ellis AK, Nowak-Wegrzyn A, Kaliner M, Lowenthal R, Tanimoto S. Casale TB, et al. J Allergy Clin Immunol. 2023 Dec;152(6):1587-1596. doi: 10.1016/j.jaci.2023.08.007. Epub 2023 Aug 19. J Allergy Clin Immunol. 2023. PMID: 37604314 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The risk of severe adverse reactions to neffy intranasal epinephrine spray

Affiliations

The risk of severe adverse reactions to neffy intranasal epinephrine spray

Authors

Affiliations

Conflict of interest statement

Comment in

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources